Insecticides (India) profit and loss

Latest FY26

Revenue: ₹2,140cr+7.0% on FY25
EBITDA: ₹227cr+2.6% on FY25
Net profit: ₹139cr−1.8% on FY25
EPS: ₹47.91−1.0% on FY25

₹ crore except per share

Tap a line for its trend	Last 12Mto Jun 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

Expenses
	2,060	2,140	2,000	1,966	1,801	FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	13.3	11.7	7.0	9.5	1.3
	2,074	2,152	2,007	1,976	1,803
	1,186	1,200	1,348	1,332	1,399
	231	170	75.1	159	112
	−23.2	95.2	−64.4	−26.1	−126
	170	164	139	117	98.4
	17.8	16.9	6.9	10.9	13.5
	37.9	35.5	29.2	29.3	26.1
	287	284	281	222	195
	1,906	1,965	1,815	1,844	1,719
	210	227	221	163	122
	172	192	192	133	95.8
Profit
	168	186	192	132	83.6
	168	186	192	132	83.6
	41.6	43.8	55.9	33.0	20.8
	1.3	3.5	−5.2	−3.1	−0.2
	42.9	47.3	50.8	29.8	20.6
	0.4	0.3	0.6	0.3	0.2
	125	139	142	102	63.2
	125	139	141	102	63.0
	0.7	2.2	−1.3	1.8	0.3
	126	142	141	104	63.5
	125	139	—	102	—
	2.4	2.2	0.0	0.0	—
Per share
	₹43.01	₹47.91	₹48.38	₹34.59	₹21.36
	₹43.01	₹47.91	₹48.38	₹34.59	₹21.28
Other comprehensive income — detail
	0.7	2.2	−1.3	—	—
	0.2	2.2	−1.3	1.8	0.3
	−0.5	0.0	0.0	—	—
	—	—	−0.0	—	—
	—	142	—	—	—
Per share — as-filed variants
	₹43.01	₹47.91	₹48.38	₹34.59	₹21.36
	₹43.01	₹47.91	₹48.38	₹34.59	₹21.28
Derived — gross profit (revenue − materials − purchases − Δ inventories)
	667	675	641	501	416
	32.4%	31.5%	32.0%	25.5%	23.1%
Adjusted (ex-exceptional items) — derived
	168	186	192	132	83.6
	125	139	142	102	63.2
	₹43.01	₹47.91	₹48.38	₹34.59	₹21.36

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

INSECTICID₹512.45

Insecticides (India) Limited

· Chemicals

Annual Quarterly₹ CrorePeersIPL MOL BHARATRAS PUNJABCHEM ASTEC GSPCROP DHARMAJ BHAGCHEMMcap ₹1,491 Cr

View

In ₹ Crore except Per Share 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Revenue from Operations	1,801.3	1,966.4	1,999.9	2,140.0	2,060.4
Other Income	1.3	9.5	7.0	11.7	13.3
Total Income	1,802.6	1,975.9	2,006.9	2,151.7	2,073.7
Expenses
+ Cost of Materials Consumed	1,399.5	1,332.2	1,348.4	1,200.2	1,185.6
+ Purchases of Stock-in-Trade	112.1	158.9	75.1	169.6	231.4
+ Changes in Inventories	-126.0	-26.1	-64.4	95.2	-23.2
+ Employee Benefit Expense	98.4	117.3	138.7	163.7	169.6
+ Finance Costs	13.5	10.9	6.9	16.9	17.8
+ Depreciation & Amortisation	26.1	29.3	29.2	35.5	37.9
+ Other Expenses	195.4	221.5	280.9	284.3	287.0
Total Expenses	1,719.0	1,844.0	1,814.8	1,965.3	1,906.1
EBITDA	121.9	162.6	221.2	227.0	210.1
EBIT	95.8	133.3	192.1	191.6	172.2
Profit
PBT before Exceptional Items	83.6	131.9	192.2	186.4	167.7
Pretax Income	83.6	131.9	192.2	186.4	167.7
+ Current Tax	20.8	33.0	55.9	43.8	41.6
+ Deferred Tax	-0.2	-3.1	-5.2	3.5	1.3
Tax Expense	20.6	29.8	50.8	47.3	42.9
+ Share of Associates & JVs	0.2	0.3	0.6	0.3	0.4
Net Income	63.2	102.4	142.0	139.4	125.2
+ Net Income — Continuing Ops	63.0	102.1	141.4	139.1	124.8
+ Other Comprehensive Income	0.3	1.8	-1.3	2.2	0.7
Total Comprehensive Income	63.5	104.1	140.7	141.6	125.9
Net Income to Common	—	102.4	—	139.4	125.2
Minority Interest	—	0.0	0.0	2.2	2.4
Per Share
Basic EPS	21.36	34.59	48.38	47.91	43.01
Diluted EPS	21.28	34.59	48.38	47.91	43.01
Other Comprehensive Income — detail
+ Other Comprehensive Income	—	—	-1.3	2.2	0.7
+ Items NOT to be Reclassified to P&L	0.3	1.8	-1.3	2.2	0.2
+ Tax on Items NOT to be Reclassified	—	—	0.0	0.0	-0.5
+ Items to be Reclassified to P&L	—	—	-0.0	—	—
Comprehensive Income — Owners of Parent	—	—	—	141.6	—
Per Share — as-filed variants
Basic EPS — Continuing Operations	21.36	34.59	48.38	47.91	43.01
Diluted EPS — Continuing Operations	21.28	34.59	48.38	47.91	43.01
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit	415.7	501.4	640.8	675.1	666.6
Gross Margin %	23.08	25.50	32.04	31.55	32.35
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)	83.6	131.9	192.2	186.4	167.7
Net Income Adj (tax-effected)	63.2	102.4	142.0	139.4	125.2
EPS Adj	21.36	34.59	48.38	47.91	43.01
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value	10.00	10.00	—	10.00	10.00
Paid Up Equity Capital	29.6	29.6	29.1	29.1	29.1

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.